The Africa CDC Biomanufacturing Fellowship Programme 2026 is a transformative initiative aimed at building a strong and skilled workforce in Africa’s growing biomanufacturing sector. Launched by the African Centres for Disease Control and Prevention (Africa CDC) under the African Union (AU), this program is designed to equip professionals with the expertise needed to advance vaccine, diagnostic, and therapeutic production across the continent.
As Africa works towards achieving its long-term development goals under Agenda 2063, this fellowship plays a critical role in strengthening public health systems and reducing dependence on imported medical products.
Background and Purpose of the Programme
Africa currently produces less than 1% of the vaccines it uses, making the continent highly dependent on external sources. This creates challenges in responding quickly to pandemics and other health emergencies.
To address this, the African Union launched the Partnerships for African Vaccine Manufacturing (PAVM) in 2021, which has now evolved into the Platform for Harmonised African Health Products Manufacturing (PHAHM). The goal is ambitious:
- Produce 60% of Africa’s vaccines locally by 2040
- Achieve interim targets of 10% by 2025 and 30% by 2030
However, achieving this vision requires a highly skilled workforce, which is currently limited. The fellowship programme is designed to bridge this gap.
Also Apply For: Sunday Markets MSMEs Growth Pitch Challenge 2026
The Challenge in Africa’s Biomanufacturing Sector
One of the major barriers to growth in Africa’s healthcare manufacturing industry is the shortage of trained professionals.
- The current workforce is estimated at around 3,000 professionals
- There is a need to almost quadruple this number
- Training programs are limited and often not flexible for working professionals
This shortage affects the continent’s ability to produce vaccines and other critical health products at scale.
The Proposed Solution
To solve this problem, Africa CDC has introduced the Biomanufacturing Fellowship Programme 2026. This initiative focuses on:
- Expanding training opportunities in biomanufacturing
- Providing hands-on industry experience
- Developing leadership and technical expertise
- Supporting professionals without requiring them to leave their jobs for long periods
The program aims to produce highly skilled experts who can drive innovation and growth in Africa’s healthcare manufacturing sector.
About the Fellowship Programme
The fellowship is a 2-year intensive programme combining both theoretical learning and practical industry experience.
Participants will:
- Gain specialized training in biomanufacturing and vaccine R&D
- Develop skills in leadership, management, and mentorship
- Learn about resource planning and entrepreneurship
- Focus on a specific area of specialization within the field
This combination ensures that fellows are well-prepared to become leaders in Africa’s healthcare industry.
Eligibility Criteria
The programme is targeted at professionals already working in biomanufacturing companies.
To qualify, applicants must meet the following requirements:
Educational Qualifications
- A Master’s degree in a relevant field, or
- A Bachelor’s degree with at least 5 years of experience in biomanufacturing
Relevant Fields
- Pharmacy and Pharmaceutical Sciences
- Biotechnology
- Chemistry and Biochemistry
- Biochemical Engineering
Additional Requirements
Applicants must also:
- Be a citizen of an African Union Member State
- Possess a valid passport
- Be available to participate in training across selected countries
The programme encourages applications from all qualified individuals, including women and underrepresented groups.
Selection Process
Applications will be reviewed by a dedicated committee set up by Africa CDC under the PHAHM initiative.
- Only 5 candidates will be selected for the programme
- Shortlisted applicants will be contacted for further evaluation
Due to the competitive nature of the fellowship, applicants are encouraged to submit strong and well-prepared applications.
Fellowship Duration
The programme will run for two years, with the following timeline:
- Start Date: July 2026
- End Date: June 2028
During this period, fellows will undergo both academic training and practical industry exposure.
Financial Support and Benefits
Africa CDC provides full funding to ensure participants can focus on learning and development.
The fellowship covers:
- Daily Subsistence Allowance (DSA) during training periods
- Return flight tickets to training locations
- Travel and health insurance
- Visa fees
- Post-fellowship allowance
This comprehensive support makes the programme accessible to talented professionals across Africa.
Important Dates
- Application Deadline: 20th April 2026
- Notification of Selected Candidates: By 1st June 2026
- Programme Start: July 2026
Applicants are advised to apply early to avoid missing the deadline.
How to Apply
Interested candidates can apply online by completing the official application form provided by the Africa CDC.
Ensure that all required details are accurately filled and that your qualifications and experience clearly match the programme requirements.
Why This Fellowship Matters
The Africa CDC Biomanufacturing Fellowship Programme 2026 is more than just a training opportunity—it is a strategic investment in Africa’s future.
By building a skilled workforce, the programme will:
- Strengthen Africa’s healthcare systems
- Improve pandemic preparedness
- Reduce dependence on imported vaccines
- Promote innovation and economic growth
For professionals in the biomanufacturing field, this fellowship offers a rare chance to gain world-class training while contributing to a vital sector.
Apply Now!
If you are a qualified professional in the biomanufacturing industry and want to play a role in shaping Africa’s healthcare future, this fellowship is an excellent opportunity.
With limited slots available, strong preparation and early application are key to success.
For more information, visit the Africa CDC Biomanufacturing Fellowship.
